IP Library Granted Patent US 10,550,398
Granted Patent B2
US 10,550,398 · App. 16/094,795 · Granted Feb 4, 2020

RlmA-inactivated filamentous fungal host cell

Inventor: Hiroshi Teramoto (Chiba, JP)
Assignee: Novozymes A/S
C12N15/80C12N9/2428
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,550,398
App. No.
16/094,795
Granted
Feb 4, 2020
Kind
B2
Abstract

The present invention relates to RImA-inactivated filamentous fungal cells secreting a polypeptide of interest and methods of producing a secreted polypeptide of interest in said cells as well as methods of producing said cells.

Claims (34)

1. An Aspergillus host cell comprising a heterologous polynucleotide encoding a secreted polypeptide of interest and comprising an inactivated rImA gene or homologue thereof, wherein said rImA gene or homologue thereof encodes an RImA polypeptide having at least 80% amino acid sequence identity with SEQ ID NO:3.

2. The host cell of claim 1 , wherein the secreted polypeptide of interest is an enzyme.

3. The host cell of claim 1 , wherein the rImA gene or homologue thereof comprises or consists of a genomic nucleotide sequence at least 80% identical to the genomic DNA sequence shown in SEQ ID NO: 1.

4. The host cell of claim 1 , wherein the rImA gene or homologue thereof comprises or consists of a genomic nucleotide sequence, the cDNA sequence of which is at least 80% identical to the cDNA sequence shown in SEQ ID NO: 2.

5. A method of producing a secreted polypeptide of interest, said method comprising the steps of:

a) cultivating an Aspergillus host cell comprising a heterologous polynucleotide encoding the secreted polypeptide of interest and comprising an inactivated rImA gene or homologue thereof under conditions conducive to the expression of the secreted polypeptide of interest, wherein said rImA gene or homologue thereof encodes an RImA polypeptide having at least 80% amino acid sequence identity with SEQ ID NO: 3; and, optionally,

b) recovering the secreted polypeptide of interest.

6. The method of claim 5 , wherein the secreted polypeptide of interest is an enzyme.

7. The method of claim 5 , wherein the rImA gene or homologue thereof comprises or consists of a genomic nucleotide sequence at least 80% identical to the genomic DNA sequence shown in SEQ ID NO: 1.

8. The method of claim 5 , wherein the rImA gene or homologue thereof comprises or consists of a genomic nucleotide sequence, the cDNA sequence of which is at least 80% identical to the cDNA sequence shown in SEQ ID NO: 2.

9. A method of producing an Aspergillus host cell having an improved yield of a secreted heterologous polypeptide of interest, said method comprising the following steps in no particular order:

a) transforming a filamentous fungal host cell with a heterologous polynucleotide encoding the secreted polypeptide of interest; and

b) inactivating an rImA gene or a homologue thereof in the filamentous fungal host cell, wherein said rImA gene or a homologue thereof encodes an RImA polypeptide having at least 80% amino acid sequence identity with SEQ ID NO: 3.

10. The method of claim 9 , wherein the secreted polypeptide of interest is an enzyme.

11. The method of claim 9 , wherein the rImA gene or homologue thereof comprises or consists of a genomic nucleotide sequence at least 80% identical to the genomic DNA sequence shown in SEQ ID NO: 1.

12. The method of claim 9 , wherein the rImA gene or homologue thereof comprises or consists of a genomic nucleotide sequence, the cDNA sequence of which is at least 80% identical to the cDNA sequence shown in SEQ ID NO: 2.

13. The host cell of claim 1 , wherein the Aspergillus cell is an Aspergillus awamori, Aspergillus foetidus, Aspergillus fumigatus, Aspergillus japonicus, Aspergillus nidulans, Aspergillus niger , or Aspergillus oryzae cell.

14. The host cell of claim 2 , wherein the enzyme is a hydrolase, isomerase, ligase, lyase, oxidoreductase, or transferase.

15. The host cell of claim 2 , wherein the enzyme is an aminopeptidase, amylase, carbohydrase, carboxypeptidase, catalase, cellobiohydrolase, cellulase, chitinase, cutinase, cyclodextrin glycosyltransferase, deoxyribonuclease, endoglucanase, esterase, alpha-galactosidase, beta-galactosidase, glucoamylase, alpha-glucosidase, beta-glucosidase, invertase, laccase, lipase, mannosidase, mutanase, oxidase, pectinolytic enzyme, peroxidase, phytase, polyphenoloxidase, proteolytic enzyme, ribonuclease, transglutaminase, xylanase, or beta-xylosidase.

16. The host cell of claim 1 , wherein the RImA polypeptide comprises or consists of an amino acid sequence at least 85% identical to the amino acid sequence shown in SEQ ID NO: 3.

17. The host cell of claim 1 , wherein the RImA polypeptide comprises or consists of an amino acid sequence at least 90% identical to the amino acid sequence shown in SEQ ID NO: 3.

18. The host cell of claim 1 , wherein the RImA polypeptide comprises or consists of an amino acid sequence at least 95% identical to the amino acid sequence shown in SEQ ID NO: 3.

19. The method of claim 5 , wherein the Aspergillus cell is an Aspergillus awamori, Aspergillus foetidus, Aspergillus fumigatus, Aspergillus japonicus, Aspergillus nidulans, Aspergillus niger , or an Aspergillus oryzae cell.

20. The method of claim 6 , wherein the enzyme is a hydrolase, isomerase, ligase, lyase, oxidoreductase, or transferase.

21. The method of claim 6 , wherein the enzyme is an aminopeptidase, amylase, carbohydrase, carboxypeptidase, catalase, cellobiohydrolase, cellulase, chitinase, cutinase, cyclodextrin glycosyltransferase, deoxyribonuclease, endoglucanase, esterase, alpha-galactosidase, beta-galactosidase, glucoamylase, alpha-glucosidase, beta-glucosidase, invertase, laccase, lipase, mannosidase, mutanase, oxidase, pectinolytic enzyme, peroxidase, phytase, polyphenoloxidase, proteolytic enzyme, ribonuclease, transglutaminase, xylanase, or beta-xylosidase.

22. The method of claim 5 , wherein the RImA polypeptide comprises or consists of an amino acid sequence at least 85% identical to the amino acid sequence shown in SEQ ID NO: 3.

23. The method of claim 5 , wherein the RImA polypeptide comprises or consists of an amino acid sequence at least 90% identical to the amino acid sequence shown in SEQ ID NO: 3.

24. The method of claim 5 , wherein the RImA polypeptide comprises or consists of an amino acid sequence at least 95% identical to the amino acid sequence shown in SEQ ID NO: 3.

25. The method of claim 10 , wherein the enzyme is a hydrolase, isomerase, ligase, lyase, oxidoreductase, or transferase.

26. The method of claim 10 , wherein the enzyme is an aminopeptidase, amylase, carbohydrase, carboxypeptidase, catalase, cellobiohydrolase, cellulase, chitinase, cutinase, cyclodextrin glycosyltransferase, deoxyribonuclease, endoglucanase, esterase, alpha-galactosidase, beta-galactosidase, glucoamylase, alpha-glucosidase, beta-glucosidase, invertase, laccase, lipase, mannosidase, mutanase, oxidase, pectinolytic enzyme, peroxidase, phytase, polyphenoloxidase, proteolytic enzyme, ribonuclease, transglutaminase, xylanase, or beta-xylosidase.

27. The method of claim 9 , wherein the RImA polypeptide comprises or consists of an amino acid sequence at least 85% identical to the amino acid sequence shown in SEQ ID NO: 3.

28. The method of claim 9 , wherein the RImA polypeptide comprises or consists of an amino acid sequence at least 90% identical to the amino acid sequence shown in SEQ ID NO: 3.

29. The method of claim 9 , wherein the RImA polypeptide comprises or consists of an amino acid sequence at least 95% identical to the amino acid sequence shown in SEQ ID NO: 3.

30. The host cell of claim 9 , wherein the Aspergillus cell is an Aspergillus awamori, Aspergillus foetidus, Aspergillus fumigatus, Aspergillus japonicus, Aspergillus nidulans, Aspergillus niger , or Aspergillus oryzae cell.

Priority Claims (2)
EP 16165997 · Apr 19, 2016 · regional
EP 16176897 · Jun 29, 2016 · regional
Continuity (1)
Related Publication 20190119690A1 · Apr 25, 2019